Cathie Wood ARK Investment Management
Cathie Wood is the founder, CEO, and CIO of ARK Investment Management, an investment firm known for its focus on “disruptive innovation”. She gained widespread attention for her bold market calls and high conviction in cutting-edge technologies such as electric vehicles, genomics, and blockchain. Under her guidance, ARK’s exchange-traded funds (ETFs) attracted substantial interest from both retail and institutional investors. Wood’s investment philosophy emphasizes research-driven analysis and long-term growth potential, positioning her as one of today’s most influential voices in the world of finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$95.6M |
| 2 |
TWOU
2U Inc
TWOU
|
+$43.5M |
| 3 |
XLNX
Xilinx Inc
XLNX
|
+$43M |
| 4 |
Nutanix
NTNX
|
+$42.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$29.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MDSO
Medidata Solutions, Inc.
MDSO
|
+$97.5M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
+$52.6M |
| 3 |
Baidu
BIDU
|
+$47.6M |
| 4 |
LendingTree
TREE
|
+$44.9M |
| 5 |
NVIDIA
NVDA
|
+$36.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 35.94% |
| 2 | Technology | 27.53% |
| 3 | Communication Services | 11.18% |
| 4 | Financials | 10.2% |
| 5 | Consumer Discretionary | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MLNX
126
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $457K | 0.01% |
4,132
-1,366
| -25% | -$157K |
|
127
Kamada
KMDA
$475M
| $452K | 0.01% |
81,874
-4,154
| -5% | -$23.8K |
|
128
Galmed Pharmaceuticals
GLMD
$4.48M
| $448K | 0.01% |
42
+5
| +14% | +$51.6K |
|
129
Allot
ALLT
$366M
| $445K | 0.01% |
+61,698
| New | +$458K |
|
|
NVMI
130
Nova
NVMI
$12B
| $442K | 0.01% |
17,266
-2,424
| -12% | -$64.8K |
|
131
GE Aerospace
GE
$361B
| $441K | 0.01% |
8,436
-805
| -9% | -$39.6K |
|
132
Medtronic
MDT
$119B
| $441K | 0.01% |
4,530
-254
| -5% | -$23.2K |
|
133
Stryker
SYK
$126B
| $438K | 0.01% |
2,129
-449
| -17% | -$85.8K |
|
|
UCTT
134
Ultra Clean Holdings
UCTT
$3.46B
| $428K | 0.01% |
30,750
-14,415
| -32% | -$184K |
|
135
Tower Semiconductor
TSEM
$25.2B
| $421K | 0.01% |
26,691
-4,970
| -16% | -$82.9K |
|
|
NUVA
136
DELISTED
NuVasive, Inc.
NUVA
| $417K | 0.01% |
7,122
-1,862
| -21% | -$110K |
|
137
Camtek
CAMT
$6.85B
| $415K | 0.01% |
49,129
-16,718
| -25% | -$154K |
|
138
Silicom
SILC
$253M
| $411K | 0.01% |
12,669
-903
| -7% | -$29.8K |
|
|
TARO
139
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $408K | 0.01% |
4,776
-210
| -4% | -$20.8K |
|
140
Ituran Location and Control
ITRN
$1.01B
| $404K | 0.01% |
13,417
-883
| -6% | -$29.8K |
|
|
RDHL
141
Redhill Biopharma
RDHL
$3.83M
| $389K | 0.01% |
60
-6
| -9% | -$46.2K |
|
142
Ceragon Networks
CRNT
$191M
| $385K | 0.01% |
131,354
+14,381
| +12% | +$47K |
|
|
SIE
143
DELISTED
SIERRA HEALTH SERVICES INC
SIE
| $384K | 0.01% |
+3,208
| New | +$384K |
|
|
NNDM
144
Nano Dimension
NNDM
$325M
| $382K | 0.01% |
79,646
-782
| -1% | -$4.85K |
|
145
Kaiser Aluminum
KALU
$2.52B
| $352K | 0.01% |
+3,609
| New | +$352K |
|
|
FOMX
146
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $349K | 0.01% |
146,745
+29,378
| +25% | +$87.8K |
|
147
United Parcel Service
UPS
$86.8B
| $346K | 0.01% |
3,352
-870
| -21% | -$90.5K |
|
148
Indaptus Therapeutics
INDP
$172M
| $336K | 0.01% |
35
+10
| +40% | +$126K |
|
|
BDT
149
DELISTED
BLACKROCK STRATEGIC EQUITY DIVIDEND TRUST COM
BDT
| $331K | 0.01% |
+4,666
| New | +$331K |
|
150
Evogene
EVGN
$8.89M
| $327K | 0.01% |
20,299
-8,376
| -29% | -$155K |
|
Similar funds
Cathie Wood's Q2 2019 Portfolio in Review
As of Q2 2019, Cathie Wood held 232 positions worth $3.97B, up 13% from $3.5B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Cathie Wood's Q2 2019 filing shows 36 new, 86 increased, 79 reduced and 25 closed positions. Its largest new stake was Meta Platforms (Facebook): 162,707 shares worth $31.4M. The largest sale was Medidata Solutions, Inc., an estimated $97.5M.
By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 34% a quarter earlier, followed by Technology and Communication Services.
- Cathie Wood's largest Q2 2019 buy was Meta Platforms (Facebook): 162,707 shares worth $31.4M.
- Cathie Wood added most to Tesla in Q2 2019, an estimated $95.6M increase.
- Cathie Wood's biggest Q2 2019 reduction was Medidata Solutions, Inc., cutting an estimated $97.5M.
- Cathie Wood fully exited Zuora, Inc. in Q2 2019, selling an estimated $7.17M.
- Cathie Wood's ten largest holdings make up 50% of its $3.97B portfolio in Q2 2019.
- Cathie Wood opened 36 new positions and closed 25 in Q2 2019.
- Cathie Wood's portfolio value rose 13% quarter-over-quarter to $3.97B.
Based on ARK Investment Management's 13F filing for Q2 2019, filed 30 Jul 2019.